Latigo Biotherapeutics, Inc. (LTGO)
NMS · Healthcare · Biotechnology
$16.57
+1.41%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.10B
Shares Outstanding
66.3M
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (21.5M) | (25.7M) | (23.4M) | (25.8M) |
| Net Income | (21.0M) | (25.8M) | (23.0M) | (25.8M) |
| Diluted EPS | $-0.48 | $-0.59 | $-0.52 | $-0.43 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (63.5M) | (110.4M) |
| Net Income | (61.2M) | (109.2M) |
| Diluted EPS | $-1.39 | $-2.48 |